4//SEC Filing
Akebia Therapeutics, Inc. 4
Accession 0001562180-16-003658
$AKBACIK 0001517022operating
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 4:05 PM ET
Size
5.5 KB
Accession
0001562180-16-003658
Insider Transaction Report
Form 4
Tubridy Karen L
SVP, Chief Development Officer
Transactions
- Award
Stock Option (Right to buy)
2016-11-30+130,000→ 130,000 totalExercise: $8.61Exp: 2026-11-30→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]This option will vest as to 25% of the shares of common stock subject to the award on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001517022
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 4:05 PM ET
- Size
- 5.5 KB